These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30851617)

  • 1. Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method.
    Kotwal P; Magotra A; Dogra A; Sharma S; Gour A; Bhatt S; Wazir P; Singh PP; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():48-55. PubMed ID: 30851617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an LC-MS/MS method for the simultaneous determination of bedaquiline and rifabutin in human plasma.
    Gray WA; Waldorf B; Rao MG; Stiles BL; Griffiss JM; Salata RA; Blumer JL
    J Pharm Biomed Anal; 2019 Nov; 176():112775. PubMed ID: 31446299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline: a review of human pharmacokinetics and drug-drug interactions.
    van Heeswijk RP; Dannemann B; Hoetelmans RM
    J Antimicrob Chemother; 2014 Sep; 69(9):2310-8. PubMed ID: 24860154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry.
    Alffenaar JW; Bolhuis M; van Hateren K; Sturkenboom M; Akkerman O; de Lange W; Greijdanus B; van der Werf T; Touw D
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5675-80. PubMed ID: 26149993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a highly sensitive LC-ESI-MS/MS method for estimation of IIIM-MCD-211, a novel nitrofuranyl methyl piperazine derivative with potential activity against tuberculosis: Application to drug development.
    Magotra A; Sharma A; Gupta AP; Wazir P; Sharma S; Singh PP; Tikoo MK; Vishwakarma RA; Singh G; Nandi U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():200-206. PubMed ID: 28623772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin and rifapentine significantly reduce concentrations of bedaquiline, a new anti-TB drug.
    Svensson EM; Murray S; Karlsson MO; Dooley KE
    J Antimicrob Chemother; 2015 Apr; 70(4):1106-14. PubMed ID: 25535219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Natural Phenolics on Pharmacokinetic Modulation of Bedaquiline in Rat to Assess the Likelihood of Potential Food-Drug Interaction.
    Kotwal P; Dogra A; Sharma A; Bhatt S; Gour A; Sharma S; Wazir P; Singh PP; Kumar A; Nandi U
    J Agric Food Chem; 2020 Feb; 68(5):1257-1265. PubMed ID: 31927919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis.
    Brill MJ; Svensson EM; Pandie M; Maartens G; Karlsson MO
    Int J Antimicrob Agents; 2017 Feb; 49(2):212-217. PubMed ID: 28038962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study.
    Bratkowska D; Shobo A; Singh S; A Bester L; Kruger HG; Maguire GE; Govender T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():187-94. PubMed ID: 25796075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetic Analysis of Bedaquiline-Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
    Kurosawa K; Rossenu S; Biewenga J; Ouwerkerk-Mahadevan S; Willems W; Ernault E; Kambili C
    J Clin Pharmacol; 2021 Oct; 61(10):1344-1355. PubMed ID: 33991350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
    Mudavath S; Ashok D
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis.
    Nguyen TV; Cao TB; Akkerman OW; Tiberi S; Vu DH; Alffenaar JW
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1025-37. PubMed ID: 27322153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
    Perrineau S; Lachâtre M; Lê MP; Rioux C; Loubet P; Fréchet-Jachym M; Gonzales MC; Grall N; Bouvet E; Veziris N; Yazdanpanah Y; Peytavin G
    Int J Tuberc Lung Dis; 2019 Jan; 23(1):99-104. PubMed ID: 30674381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers.
    Healan AM; Griffiss JM; Proskin HM; O'Riordan MA; Gray WA; Salata RA; Blumer JL
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations.
    Hu M; Zheng C; Gao F
    Drug Des Devel Ther; 2016; 10():3983-3994. PubMed ID: 27994440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
    Centers for Disease Control and Prevention
    MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
    Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
    Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
    Xu J; Tasneen R; Peloquin CA; Almeida DV; Li SY; Barnes-Boyle K; Lu Y; Nuermberger E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.